TotalMarketCap

TransMedics Group

TMDXNasdaq United StatesHealth CareBiotechnology: Electromedical & Electrotherapeutic Apparatus

Market cap

$2.398 B

$69.15 -4.96%

Close of 6 Nov 2026

As of 6 Nov 2026, TransMedics Group (TMDX) has a market capitalization of $2.40B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$605.5M

#1799 by revenue

Earnings

$190.3M

#1016 by earnings

Shares outstanding

34,733,883

Latest filing cover page

P/E ratio

12.6

Cap ÷ net income

Biotechnology: Electromedical & Electrotherapeutic Apparatus, ranked by market cap

All 26 →
  1. #3IntegerITGR$4.31B
  2. #4AxogenAXGN$2.92B
  3. #5TransMedics GroupTMDX$2.40B
  4. #6CONMEDCNMD$1.57B
  5. #7CeribellCBLL$1.01B

What if TransMedics Group were worth as much as…

Open the what-if tool →

Gold $28.2T

$814,326.05

Per share 11,776× higher

Bitcoin $1.53T

$44,061.76

Per share 637× higher

Apple $5.02T

$144,650.66

Per share 2,092× higher

Or at a round number

$5.00B$10.0B$20.0B$50.0B

Where these numbers come from

Share counts and financials for TransMedics Group are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.